Remote Jobs at ProKidney Corp.
Find your next remote opportunity · 1 Open Position
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research.
ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive meaningful improvement in kidney function.
Late-stage CKD, Stage 3b - 4, is a key target for REACT™ therapy.
REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program, which launched in January 2022.
For more information, visit www.prokidney.com.
Director, CMC Project Management
CMC project director advancing ProKidney’s cell therapy programs toward BLA filing and approval. Leading cross-functional planning, risk management and Technical Operations deliverables.
No more jobs available.